Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Prognostic Value of Pre-Therapy Serum Uric Acid in Diffuse Large B-Cell Lymphoma

Shenxian Qian, MD, Li Yiwei, Resident

Blood (2018) 132 (Supplement 1): 5418.

https://doi.org/10.1182/blood-2018-99-112684

Published: 2018

Journal Articles

Hyperuricemia and Musculoskeletal Complications in Thalassemia Patients

Juthatip Chaloemwong, MD, Adisak Tantiworawit, MD, Worawit Louthrenoo, MD, Thanawat Rattanathammethee, MD, Sasinee Hantrakool, MD, Chatree Chai-Adisaksopha, MD, Ekarat Rattarittamrong, MD, Lalita Norasetthada, MD

Blood (2017) 130 (Supplement 1): 4761.

https://doi.org/10.1182/blood.V130.Suppl_1.4761.4761

Published: 2017

Journal Articles

Febuxostat Pharmacokinetic/Pharmacodynamic Bridging from Adults to Pediatrics for Effective Prophylaxis of Tumor Lysis Syndrome: From Florence to Floret Study

Michele Spina, MD, Paolo Mazzei, PhD, Simone Baldini, MD, Marta Pedretti, MD PhD, Enrica Mezzalana, PhD, Mariagiuseppa Matera, PhD, Silvia Manunta, MD, Giulia Calamai, Alessandra Scordari, PhD, Simona Scartoni, Angela Capriati, MD PhD, Cecilia Simonelli, MD, Franco Locatelli, MD

Blood (2015) 126 (23): 4868.

https://doi.org/10.1182/blood.V126.23.4868.4868

Published: 2015

Journal Articles

Title in Chemotherapy for Acute Myeloid Leukemia with High Leukocyte Counts.

Taiichi Kyo, MD, Ryota Imanaka, MD, Tetsuro Ochi, MD, Takeshi Okatani, MD, Kohei Kyo, MD, Mitsuhiro Itagaki, MD, Hisao Nagoshi, MD, Yuta Katayama, MD, Koji Iwato, MD, Hideki Asaoku, MD

Blood (2014) 124 (21): 5272.

https://doi.org/10.1182/blood.V124.21.5272.5272

Published: 2014

Journal Articles

Decision Driven Factors for Allopurinol Dosage in Tumor Lysis Syndrome Prophylaxis: The European Experience of the Florence Pivotal Study

Blood (2014) 124 (21): 5979.

https://doi.org/10.1182/blood.V124.21.5979.5979

Published: 2014

Journal Articles

Serum Uric Acid Levels during Allogeneic Hematopoeitic Cell Transplantation and Subsequent Graft Versus Host Disease

Albert C Yeh, MD, Thomas R. Spitzer, MD, Yi-Bin Chen, MD, Steven McAfee, MD, Karen K. Ballen, MD, Eyal C. Attar, MD, Amir T. Fathi, MD, Bimalangshu R. Dey, MD PhD

Blood (2014) 124 (21): 2493.

https://doi.org/10.1182/blood.V124.21.2493.2493

Published: 2014

Journal Articles

An Intergenic SNP in the β–globin Gene Cluster Is Associated with Hyperuricemia and Influences Gene Transcription in Vitro

Chutima Kumkhaek, PhD, Daniel Shriner, PhD, Ayo P. Doumatey, PhD, Charles N. Rotimi, PhD, Griffin P. Rodgers, MD

Blood (2014) 124 (21): 1362.

https://doi.org/10.1182/blood.V124.21.1362.1362

Published: 2014

Journal Articles

Incidence of Treatment-Related, Laboratory and Clinical Tumor Lysis Syndrome

Mitchell S. Cairo, MD, Stephen Thompson, Lee Stern, Steven Sherman, MS

Blood (2012) 120 (21): 238.

https://doi.org/10.1182/blood.V120.21.238.238

Published: 2012

Journal Articles

Botezomib Containing Regimens Provide a Rapid Hematological and Cardiac Response in Patients with AL Amyloidosis

Victor H Jimenez-Zepeda, MD, PD, Donna Reece, Suzanne Trudel, MD, MSC, FRCPC, Christine I. Chen, MD, Rodger E. Tiedemann, MD, PhD, FRACP, FRCPA, Vishal Kukreti, MD

Blood (2012) 120 (21): 4064.

https://doi.org/10.1182/blood.V120.21.4064.4064

Published: 2012

Journal Articles

Urate Oxidase (Rasburicase) to Inhibit Graft Versus Host Disease (GVHD) After Myeloablative HLA-Matched Allogeneic Hematopoietic Cell Transplantation (HCT).

Andrew M. Brunner, MD, Thomas R. Spitzer, MD, Yi-Bin A. Chen, MD, Erin Coughlin, Steven L. McAfee, MD, Karen K. Ballen, MD, Eyal C. Attar, MD, Martin Caron, Frederic I. Preffer, PhD, Beow Y Yeap, ScD, Bimalangshu R Dey, MD

Blood (2012) 120 (21): 3063.

https://doi.org/10.1182/blood.V120.21.3063.3063

Published: 2012

Journal Articles

Serum Uric Acid As a Predictor Factor of the Response to Deferasirox Therapy for Patients with b-Thalassemia Major

Efthimia Vlachaki, Vasileios Perifanis, Antonia Kondou, Nikolaos Neokleous, Aikaterini Teli, Marina Oikonomou

Blood (2011) 118 (21): 5306.

https://doi.org/10.1182/blood.V118.21.5306.5306

Published: 2011

Journal Articles

Serum Uric Acid Levels Can Serve As a Sensitive Biomarker for Immunologic Activity in Patients Undergoing Hematopoietic Cell Transplantation

Sebastian P. Haen, Vicky Eyb, Nora Roth, Christoph Faul, MD, Hans-Georg Rammensee, Lothar Kanz, MD, Wolfgang A. Bethge, MD

Blood (2011) 118 (21): 4558.

https://doi.org/10.1182/blood.V118.21.4558.4558

Published: 2011

Journal Articles

Randomized Clinical Trial of Rasburicase Administered as a Standard Fixed Five Days Dosing Vs a Single Dose Followed by as Needed Dosing in Adult Patients with Hematologic Malignancies at Risk for Developing Tumor Lysis Syndrome.

Saroj Vadhan-Raj, MD, Luis Fayad, MD, Michelle Fanale, M.D., Barbara Pro, Alma Rodriguez, Frederick Hagemeister, Kandice Ames, RN, Carlos E. Bueso-Ramos, MD, Xiao Zhou, MD, PHD, Peter McLaughlin, Nathan Fowler, Jatin Shah, MD, Felipe Samaniego, MD, Anas Younes, MD, Larry Kwak, MD, PHD, Jorge Romaguera, MD

Blood (2009) 114 (22): 105.

https://doi.org/10.1182/blood.V114.22.105.105

Published: 2009

Journal Articles

Sickle Cell Leg Ulcers Are Associated with Hyperuricemia, Hemolysis, Pulmonary Hypertension and Death.

Caterina P. Minniti, MD, Mariana Hildesheim, Vandana Sachdev, MD, Darlene Allen, Oswaldo Castro, MD, James G Taylor, VI, MD, Gregory J. Kato, MD

Blood (2009) 114 (22): 2583.

https://doi.org/10.1182/blood.V114.22.2583.2583

Published: 2009

Journal Articles

ICAM-1(CD54) and Tissue Factor (CD142) Monocytes Expression Among Sickle Cell Anemia Steady-State Children: Association with VCAM-1 and ICAM-1 Soluble and Cytokines Related to Inflamossome and Th17 Response.

Wendell Vilas Boas, Sr., Bruno Antônio Veloso Cerqueira, Sr., Angela MD Zanette, MD, Jorge Clarêncio, Sr., Daniela Andrade, Jr., Marilda Souza Goncalves, Dr

Blood (2009) 114 (22): 1546.

https://doi.org/10.1182/blood.V114.22.1546.1546

Published: 2009

Journal Articles

Effectiveness of a Single 3 Mg Rasburicase Dose for the Management of Hyperuricemia in Patients with Hematologic Malignancies.

Steven M Trifilio, Judy Pi, Mary Golf, Katherine Coyle, Debbie Greenberg, Jennifer Zook, Diane Newman, Molly Koslowsky, Jayesh Mehta

Blood (2009) 114 (22): 2479.

https://doi.org/10.1182/blood.V114.22.2479.2479

Published: 2009

Journal Articles

Rasburicase Effectively Lowers Serum Uric Acid Levels in High Risk, Poor Performance Status Patients with Hematologic Malignancies

Doris Ponce, MD, Delong Liu, MD, PhD, Muhammad Rasul, MD, Nasir Ahmed, MD, Marie Dimicco, PhD, Karen Seiter, MD

Blood (2008) 112 (11): 4012.

https://doi.org/10.1182/blood.V112.11.4012.4012

Published: 2008

Journal Articles

Superiority of Rasburicase Versus Allopurinol on Serum Uric Acid Control in Adult Patients with Hematological Malignancies at Risk of Developing Tumor Lysis Syndrome : Results of a Randomized Comparative Phase III Study.

Jorge Cortes, MD, Karen Seiter, MD, Richard Thomas Maziarz, MD, Meir Wetzler, MD, Michael Craig, MD, Jeffrey Matous, Selina Luger, MD, Bimalangshu Dey, MD, Gary J. Schiller, MD, FACP, Dat Pham, MD, Camille N. Abboud, MD, FACP, Muthuswamy Krishnamurthy, MD, Archie Brown, Jr., MD, Joseph O. Moore, MD

Blood (2008) 112 (11): 919.

https://doi.org/10.1182/blood.V112.11.919.919

Published: 2008

Journal Articles

Serum Uric Acid Is a Novel Prognostic Factor in Patients with Primary Systemic Amyloidosis.

Shaji K. Kumar, MD, Angela Dispenzieri, MD, Martha Q. Lacy, MD, Suzanne R. Hayman, MD, Nelson Leung, MD, Steven R. Zeldenrust, MD, PhD, Francis K. Buadi, MD, Robert A. Kyle, MD, Vincent Rajkumar, MD, Morie A. Gertz, MD

Blood (2007) 110 (11): 658.

https://doi.org/10.1182/blood.V110.11.658.658

Published: 2007

Journal Articles

Prognostic Significance of β-2 Microglobulin Levels in Acute Myeloid Leukemia: Analysis of 1293 Patients.

Apostolia-Maria Tsimberidou, MD, PhD, Hagop M. Kantarjian, M.D., Michael J. Keating, M.D., Susan O’Brien, M.D., Sijin Wen, M.S., Jorge Cortes, M.D., Francis Giles, M.D., Charles Asa Koller, M.D., Guillermo Garcia-Manero, M.D., Sherry Pierce, B.S.N., Mark Brandt, Emil J. Freireich, M.D., Elihu H. Estey, M.D.

Blood (2006) 108 (11): 802.

https://doi.org/10.1182/blood.V108.11.802.802

Published: 2006

NARROW

Prognostic Value of Pre-Therapy Serum Uric Acid in Diffuse Large B-Cell Lymphoma

Hyperuricemia and Musculoskeletal Complications in Thalassemia Patients

Febuxostat Pharmacokinetic/Pharmacodynamic Bridging from Adults to Pediatrics for Effective Prophylaxis of Tumor Lysis Syndrome: From Florence to Floret Study

Title in Chemotherapy for Acute Myeloid Leukemia with High Leukocyte Counts.

Decision Driven Factors for Allopurinol Dosage in Tumor Lysis Syndrome Prophylaxis: The European Experience of the Florence Pivotal Study

Serum Uric Acid Levels during Allogeneic Hematopoeitic Cell Transplantation and Subsequent Graft Versus Host Disease

An Intergenic SNP in the β–globin Gene Cluster Is Associated with Hyperuricemia and Influences Gene Transcription in Vitro

Incidence of Treatment-Related, Laboratory and Clinical Tumor Lysis Syndrome

Botezomib Containing Regimens Provide a Rapid Hematological and Cardiac Response in Patients with AL Amyloidosis

Urate Oxidase (Rasburicase) to Inhibit Graft Versus Host Disease (GVHD) After Myeloablative HLA-Matched Allogeneic Hematopoietic Cell Transplantation (HCT).

Serum Uric Acid As a Predictor Factor of the Response to Deferasirox Therapy for Patients with b-Thalassemia Major

Serum Uric Acid Levels Can Serve As a Sensitive Biomarker for Immunologic Activity in Patients Undergoing Hematopoietic Cell Transplantation

Randomized Clinical Trial of Rasburicase Administered as a Standard Fixed Five Days Dosing Vs a Single Dose Followed by as Needed Dosing in Adult Patients with Hematologic Malignancies at Risk for Developing Tumor Lysis Syndrome.

Sickle Cell Leg Ulcers Are Associated with Hyperuricemia, Hemolysis, Pulmonary Hypertension and Death.

ICAM-1(CD54) and Tissue Factor (CD142) Monocytes Expression Among Sickle Cell Anemia Steady-State Children: Association with VCAM-1 and ICAM-1 Soluble and Cytokines Related to Inflamossome and Th17 Response.

Effectiveness of a Single 3 Mg Rasburicase Dose for the Management of Hyperuricemia in Patients with Hematologic Malignancies.

Rasburicase Effectively Lowers Serum Uric Acid Levels in High Risk, Poor Performance Status Patients with Hematologic Malignancies

Superiority of Rasburicase Versus Allopurinol on Serum Uric Acid Control in Adult Patients with Hematological Malignancies at Risk of Developing Tumor Lysis Syndrome : Results of a Randomized Comparative Phase III Study.

Serum Uric Acid Is a Novel Prognostic Factor in Patients with Primary Systemic Amyloidosis.

Prognostic Significance of β-2 Microglobulin Levels in Acute Myeloid Leukemia: Analysis of 1293 Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only